Sign Up Today and Learn More About Sherlock Biosciences Stock
Invest in or calculate the value of your shares in Sherlock Biosciences or other pre-IPO companies through EquityZen's platform.
Sherlock Biosciences Stock (SHBI)
Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.
About Sherlock Biosciences Stock
Founded
2019
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions. It leverages engineering biology tools, including CRISPR and Synthetic Biology, to create molecular diagnostics that can rapidly deliver accurate results for a vast range of needs in virtually any setting. They combine the diagnostic power of SHERLOCK with that of a second core platform technology, Internal Splint-Pairing Expression Cassette Translation Reaction, or INSPECTRTM, to create diagnostic tools that are simple and easy to use in virtually any setting, and at the same time provide accurate, rapid and affordable results. SheSherlock Biosciences was founded in 2019 and is headquartered in Cambridge, Massachusetts, United States.
Sherlock Biosciences Press Mentions
Stay in the know about the latest news on Sherlock Biosciences
Gene Editing Market Research Report 2025-2029 - Biotech Leaders Drive Innovation as Gene Editing Becomes Key to Sustainable Solutions
globenewswire • Jun 03, 2025
Home Diagnostics Market Strategies and Trends Forecasts Report 2025: New Analytic Technologies Promise a Dynamic Shift in the Global Diagnostic Market
globenewswire • May 28, 2025
Nucleic acid preparation
patents • May 04, 2025
Methods for polypeptide purification
patents • May 04, 2025
Improved crispr-cas technologies
patents • May 04, 2025
Sherlock Biosciences Management
Leadership team at Sherlock Biosciences
Co-Founder & Chair of Advisory Board
Feng Zhang
Co-Founder & Director
Jim Collins
Join now and verify your accreditation status to gain access to:
- Sherlock Biosciences Current Valuation
- Sherlock Biosciences Stock Price
- Sherlock Biosciences Management
- Available deals in Sherlock Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Sherlock Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Sherlock Biosciences Revenue and Financials
- Sherlock Biosciences Highlights
- Sherlock Biosciences Business Model
- Sherlock Biosciences Risk Factors
- Sherlock Biosciences Research Report from SACRA Research
Trading Sherlock Biosciences Stock
How to invest in Sherlock Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Sherlock Biosciences through EquityZen funds. These investments are made available by existing Sherlock Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Sherlock Biosciences stock?
Shareholders can sell their Sherlock Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
